Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection

Autor: April C. Pettit, Andrew J.M. Nel, David W. Wright, Carlos Zamudio, Frederick R. Haselton, Mark L. Baglia, Megan E. Pask, Keersten M. Ricks, Keertan Dheda, Hali Bordelon, Francesca Solinas, Patricia K. Russ, Tatiana Cáceres, Philip A. Short, Jonathan Michael Blackburn
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Urine/microbiology
Polymerase Chain Reaction/methods
HIV Infections
Urine
Polymerase Chain Reaction
law.invention
Mice
chemistry.chemical_compound
South Africa
law
Polymerase chain reaction
Tuberculosis/complications/diagnosis/microbiology/urine
Coinfection
Glyceraldehyde-3-Phosphate Dehydrogenases
Molecular Diagnostic Techniques
Gene Targeting
Microbiology (medical)
Genetic Markers
Tuberculosis
030106 microbiology
HIV Infections/complications
Gene Targeting/methods
Mice/genetics
Biology
Mycobacterium tuberculosis/genetics/isolation & purification
Microbiology
Sensitivity and Specificity
Article
03 medical and health sciences
Tuberculosis diagnosis
medicine
Humans
Animals
Glyceraldehyde-3-Phosphate Dehydrogenases/genetics
Peptide Fragments/genetics
purl.org/pe-repo/ocde/ford#1.06.01 [https]
Molecular Biology
Retrospective Studies
Base Sequence
Molecular Diagnostic Techniques/methods
DNA
Mycobacterium tuberculosis
DNA/isolation & purification
medicine.disease
DNA extraction
Virology
Molecular biology
Peptide Fragments
030104 developmental biology
chemistry
Genetic marker
Nucleic acid
Popis: Urine samples are increasingly used for diagnosing infections including Escherichia coli, Ebola virus, and Zika virus. However, extraction and concentration of nucleic acid biomarkers from urine is necessary for many molecular detection strategies such as polymerase chain reaction (PCR). Since urine samples typically have large volumes with dilute biomarker concentrations making them prone to false negatives, another impediment for urine-based diagnostics is the establishment of appropriate controls particularly to rule out false negatives. In this study, a mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) DNA target was added to retrospectively collected urine samples from tuberculosis (TB)-infected and TB-uninfected patients to indicate extraction of intact DNA and removal of PCR inhibitors from urine samples. We tested this design on surrogate urine samples, retrospective 1 milliliter (mL) urine samples from patients in Lima, Peru and retrospective 5 mL urine samples from patients in Cape Town, South Africa. Extraction/PCR control DNA was detectable in 97% of clinical samples with no statistically significant differences among groups. Despite the inclusion of this control, there was no difference in the amount of TB IS6110 Tr-DNA detected between TB-infected and TB-uninfected groups except for samples from known HIV-infected patients. We found a increase in TB IS6110 Tr-DNA between TB/HIV co-infected patients compared to TB-uninfected/HIV-infected patients (N=18, p=0.037). The inclusion of an extraction/PCR control DNA to indicate successful DNA extraction and removal of PCR inhibitors should be easily adaptable as a sample preparation control for other acellular sample types.
Databáze: OpenAIRE